Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 2157-2163

  Tan, Yuying ^a   Sun, Xinghua ^a   Xu, Mingxu ^a   Tan, Xuezhong ^a   Sasson, Aaron ^a   Rashidi, Babak ^a   Han, Qinghong ^a   Tan, Xiuying ^a   Wang, Xiaoen ^a   An, Zili ^a   Sun, Fan Xian ^a   Hoffman, Robert M ^a  

^a ANTICANCER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL; METHIONINE GAMMA LYASE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CANCER REGRESSION; COLON TUMOR; DRUG EFFICACY; DRUG POTENTIATION; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBON-SULFUR LYASES; CELL DIVISION; CISPLATIN; COLONIC NEOPLASMS; FEMALE; HUMANS; METHIONINE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECOMBINANT PROTEINS; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 6544274835     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Cancer Facts and Figures-1996. New York: American Cancer Society, Inc., 1996.
2. Boring, C. C., Squires, T. S., and Tong, T. Cancer statistics 1991. CA Cancer J. Clin., 41: 19-36, 1991.
3. Machover, D., Grison, X., Goldschmidt, E., Zittoun, J., Lotz, J. P., Metzger, G., Richaud, J., Hannoun, L., Marquet, J., Guillot, T., Salmon, R., Sezeur, A., Mauban, S., Parc, R., and Izrael, V. 5-Fluorouracil combined with the pure [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study. J. Natl. Cancer Inst., 84: 321-327, 1992.
4. Machover, D., Goldschmidt, E., Chollet, P., Metzger, G., Zittoun, J., Marquet, J., Vandenbulcke, J. M., Misset, J. L., Schwarzenberg, L., and Fourtillan, J. B. Treatment of advanced colorectal and gastric carcinomas with 5-fluorouracil and high-dose folinic acid. J. Clin. Oncol., 4: 685-696, 1986.
5. Hoffman, R. M., and Erbe, R. W. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc. Natl. Acad. Sci. USA, 73: 1523-1527, 1976.
6. Hoffman, R. M. Altered methionine metabolism, DNA methylation, and oncogene expression in carcinogenesis: a review and synthesis. Biochem. Biophys. Acta, 738: 49-87, 1984.
7. Guo, H., Herrera, H., Groce, A., and Hoffman, R. M. Expression of the biochemical defect of methionine dependence in fresh patient tumor in primary histoculture. Cancer Res., 53: 2479-2483, 1993.
8. Kreis, W., and Goodenow, M. Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. Cancer Res., 38: 2259-2262, 1978.
9. Xu, M., Tan, Y., Sun, X., Olbina, G., Tan, X. Z., Tan, X. Y., and Hoffman, R. M. Altered methionine metabolism: a tumor-selective therapeutic approach to cancers of many types and genotypes in the NCI screen. Proc. Am. Assoc. Cancer Res., 39: 426, 1998.
10. Goseki, N., Yamazaki, S., Shimojyu, K., Kando, F., Maruyama, M., Endo, M., Koike, M., and Takahashi, H., Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: A randomized, prospective clinical trial. Jpn. J. Cancer Res., 86: 484-489, 1995.
11. Goseki, N., Endo, M., Onodera, T., and Kosaki, G. Anti-tumor effect of L-methionine deprived total parenteral nutrition with 5-fluorouracil administration on Yoshida sarcoma-bearing rats. Ann. Surg., 214: 83-88, 1991.
12. Nagahama, T., Goseki, N., and Endo, M. Doxorubicin and vincristine with methionine depletion contributed to survival in the Yoshida sarcoma bearing rats. Anticancer Res., 18: 25-31, 1998.
13. Tan., Y., Xu, M., Guo, H., Sun, X., Kubota, T., and Hoffman, R. M. Anticancer efficacy of methioninase in vivo. Anticancer Res., 16: 3931-3936, 1996.
14. Tan, Y., Xu, M., Tan, X. Z., Tan, X., Wang., X., Saikawa, S., Nagahama, T., Sun, X., Lenz, M., and Hoffman, R. M. Overexpression and large-scale production of recombinant L-methionine-α-deamino-γ-mercaptomethane-lyase for novel anticancer therapy. Protein Express. Purif., 9: 233-245, 1997.
15. Guo, H., Lishko, V., Herrera, H., Groce, A., Kubota, T., and Hoffman, R. M. Therapeutic tumor specific cell-cycle block induced by methionine starvation in vivo. Cancer Res., 53: 5676-5679, 1993.
16. Mecham, J. O., Rowitch, D., Wallace, C. D., Stern, P. H., and Hoffman, R. M. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem. Biophys. Res. Commun., 117: 429-434, 1983.
17. Scanlon, K. J., Newman, E. M., Lu, Y., and Priest, D. G. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc. Natl. Acad. Sci. USA, 83: 8923-2825, 1986.
18. Shionoya, S., Lu, Y., and Scanlon, K. J. Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diam-minedichloroplatinum (II). Cancer Res., 46: 3445-3448, 1986.
19. Mineura, K., Sasajima, T., Sasajima, H., and Kowada, M. Inhibition of methionine uptake by cis-diamminedichloroplatinum (II) in experimental brain tumors. Int. J. Cancer, 67: 681-683, 1996.
20. Hoshiya, Y., Kubota, T., Matsuzaki, S., Kitajima, M., and Hoffman, R. M. Methionine starvation modulates the efficacy of cisplatin on human breast cancer in nude mice. Anticancer Res., 16: 3515-3518, 1996.
21. Lishko, V. K., Lishko, O. V., and Hoffman, R. M. The preparation of endotoxin-free L-methionine-α-deamino-γ-mercaptomethane-lyase (L-methioninase) from Pseudomonas putida. Protein Express. Purif., 4: 529-533, 1993.
22. Boyd, M. R. The NCI in vitro anticancer drug discovery screen. In: B. Teicher (ed.), Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, pp. 23-42. Totowa, NJ: Humana Press, Inc., 1997.
23. The nude mouse and anticancer drug evaluation. In: T. Nomura, Y. Sakurai, and M. Inaba (eds.), The Nude Mouse and Anticancer Drug Evaluation. Tokyo: Japanese Journal of Cancer and Chemotherapy Publishers, 1996.
24. Tan, Y., Zavala, J., Sr., Han, Q., Xu, M., Sun, X., Tan, X. Z., Tan, X., Magana, R., Geller, J., and Hoffman, R. M. Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients. Anticancer Res., 17: 3857-3860, 1997.
25. Lishko, V. K., Lishko, O. V., and Hoffman, R. M. Depletion of serum methionine by methioninase in mice. Anticancer Res., 13: 1465-1468, 1993.
26. Benz, C., Cadman, E., Gwin, J., Wu, T., Amara, J., Eisenfeld, A., and Dannies, P. Tamoxifen and 5-fluorouracil in breast cancer: cytotoxic synergism in vitro. Cancer Res., 43: 5298-5303, 1983.
27. Tan, Y., Epstein, L. B., and Armstrong, R. D. In vitro evaluation of 6-thioguanine and α-interferon as a therapeutic combination in HL-60 and natural killer cells. Cancer Res., 49: 4431-4434, 1989.
28. Stern, P. H., and Hoffman, R. M. Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J. Natl. Cancer Inst., 76: 629-639, 1986.
29. 6-methylguanine-DNA methyltransferase by methionine in human tumour cells. Br. J. Cancer, 75: 779-788, 1997.
30. Kokkinakis, D. M., Schold, S. C., Hori, H., and Nobori, T., Effect of long-term depletion of plasma methionine on the growth and survival of human brain tumor xenografts in athymic mice. Nutr. Cancer, 29: 195-204, 1997.
31. Hoshiya, Y., Kubota, T., Inada, T., Kitajima, M., and Hoffman, R. M. Methionine-depletion modulates the efficacy of 5-fluorouracil in human gastric cancer in nude mice. Anticancer Res., 17: 4371-4376, 1997.
32. Yoshioka, T., Wada, T., Uchida, N., Maki, H., Yoshida, H., Ide, N., Kasai, H., Hojo, K., Shono, K., Maekawa, R., Yagi, S., Hoffman, R. M., and Sugita, K. Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase. Cancer Res., 58: 2583-2587, 1998.
33. Poirson-Bichat, F., Gonfalone, G., Bras-Goncalves, R. A., Dutrillaux, B., and Poupon, M. F. Growth of methionine-dependent human prostate cancer (PC-3) is inhibited by ethionine combined with methionine starvation. Br. J. Cancer, 75: 1605-1612, 1997.
34. Poirson-Bichat, F., Lopez, R., Bras-Goncalves, R. A., Miccoli, L., Bourgeois, Y., Demerseman, P., Poisson, M., Dutrillaux, B., and Poupon, M. F. Methionine deprivation and methionine analogs inhibit cell proliferation and growth of human xenografted gliomas. Life Sci., 60: 919-931, 1997.
35. Guo, H., Tan, Y., Kubota, T., Moossa, A. R., and Hoffman, R. M. Methionine depletion modulates the antitumor and antimetastatic efficacy of ethionine. Anticancer Res., 16: 2719-2723, 1996.